Dachaigh › Fibrosis Cystic › Kansas › Kansas City
Sgrùdaidhean clionaigeach Fibrosis Cystic ann an Kansas City, KS
Tha 13 sgrùdaidhean airson Fibrosis Cystic a’ lorg phàirtichean aig làraichean ann agus timcheall air Kansas City (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Phase 2 Study to Assess the Safety and Efficacy of ANG003
A’ fastadhÌre 2
- University of Kansas Medical Center, Kansas City
Sinus Disease in Young Children With Cystic Fibrosis
A’ fastadhSgrùdadh amharc
- University of Kansas Medical Center, Kansas City
Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children
A’ fastadhSgrùdadh amharc
- University of Kansas Medical Center, Kansas City
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
A’ fastadhÌre 4
- University of Kansas Medical Center, Kansas City
4D-710 in Adult Patients With Cystic Fibrosis
A’ fastadhÌre 2
- University of Kansas Medical Center, Kansas City
Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Muco-Obstructive Lung Disease
A’ fastadhSgrùdadh amharc
- University of Kansas Medical Center, Kansas City
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
A’ fastadhÌre 1Fàilte do shaor-thoilich fhallain
- University of Kansas Medical Center, Kansas City
Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function
A’ fastadhÌre 2
- University of Kansas Medical Center, Kansas City
Health Outcomes of Parents With Cystic Fibrosis-Aim 2
A’ fastadhSgrùdadh amharc
- University of Kansas Medical Center, Kansas City
Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
A’ fastadhSgrùdadh amharc
- Kansas University Medical Center, Kansas City
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
A’ fastadhSgrùdadh amharc
- University of Kansas Medical Center, Kansas City
Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.
A’ fastadhÌre 2
- University of Kansas Medical Center, Kansas City
A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)
A’ fastadhÌre 1/2
- University of Kansas Medical Center, Kansas City
Sgrùdaidhean Fibrosis Cystic ann am bailtean eile
- Boston, MA17 sgrùdaidhean
- Birmingham, AL16 sgrùdaidhean
- Philadelphia, PA15 sgrùdaidhean
- Seattle, WA12 sgrùdaidhean
- Baltimore, MD12 sgrùdaidhean
- Denver, CO11 sgrùdadh
- Pittsburgh, PA11 sgrùdadh
- Dallas, TX11 sgrùdadh
- Cincinnati, OH10 sgrùdaidhean
- Los Angeles, CA9 sgrùdaidhean
- Aurora, CO9 sgrùdaidhean
- Minneapolis, MN8 sgrùdaidhean
Sgrùdaidhean eile ann an Kansas City
- Galarachd Cardiovasculach14 sgrùdaidhean
- Fàilligeadh a' Chridhe13 sgrùdaidhean
- Obesity13 sgrùdaidhean
- Galaran sgamhain eadar-fhillte13 sgrùdaidhean
- Aillse a' bhroilleach12 sgrùdaidhean
- Aillse sa bhlaire12 sgrùdaidhean
- Leukemia myeloid geur12 sgrùdaidhean
- Aillse Prostata12 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag11 sgrùdadh
- Ailseachadh nan Sgamhan11 sgrùdadh
- COPD9 sgrùdaidhean
- Asma8 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.